Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Tracking Cellular Pharmacokinetic Changes over Time based on Piecewise Modeling using a Continuously Infused Microfluidic Radioassay System

Kuangyu Shi, Zhen Liu, Ziying Jian, Tao Cheng, Qian Wang, Benedikt Feuerecker, Markus Schwaiger, Sung-Cheng Huang and Sibylle Ziegler
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1062;
Kuangyu Shi
1Nuclear Medicine Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhen Liu
1Nuclear Medicine Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ziying Jian
1Nuclear Medicine Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tao Cheng
1Nuclear Medicine Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qian Wang
1Nuclear Medicine Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benedikt Feuerecker
1Nuclear Medicine Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Schwaiger
1Nuclear Medicine Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sung-Cheng Huang
2University of California, Los Angeles Los Angeles CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sibylle Ziegler
1Nuclear Medicine Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1062

Objectives Capturing cellular adaptation under interventions may give insight in tumor biology and therapy. However, noise in the measurements prevents the online modeling in a short time window. We propose a continuously infused microfluidic radioassay (CIMR) system to trace real-time the pharmacokinetics by piecewise modeling.

Methods The CIMR system consists of a microfluidic slide integrated with a Timepix positron camera. The medium with radioactive tracer is driven by the pump from the medium reservoir via the medium monitoring chamber into the cell culture chamber. The medium monitoring chamber and the cell culture chamber were simultaneously measured by a positron camera with very high efficiency during the measurements. Time activity curves (TACs) were generated to describe the changes of mean event density versus time. The calibrated radioactivity of the medium in the cell chamber was estimated based on the measured TAC of the medium chamber after correction of delay and dispersion. The short time cellular pharmacokinetics was estimated using a piece-wise cellular Patlak model. Time-activity data were analyzed using a sliding time window of 6 min. The physical precision and biological stability of the CIMR system was tested on human breast cancer cells SkBr3 incubated with medium of 3 different glucose concentrations (5 mM, 2.5 mM & 0.5 mM). The piecewise modeling was first tested with simulated noisy data generated using a cellular two-compartment model with variable pharmacokinetic parameters. Furthermore, SkBr3 were measured with [18F]FDG on the CIMR system for 30 min. Then the glucose transporter inhibitor Cytochalasin B (2 µM) was added to the radioactive medium and the measurements were continued for 55 min. The experiment was repeated 3 times.

Results The test under static culturing condition showed that CIMR has high-quality dynamic measurements and high biological stability (variation of 18.5% for 5 mM, 15.1% for 2.5 mM and 5.4% for 0.5 mM). Based on the simulations, the estimated real-time Ki reproduces the ground truth with an average error of 4.4±2.8%. Under the Cytochalasin B intervention, the estimated Ki changes from ~0.037 min-1 to ~0.007 min-1, which is reproducible in the 3 SkBr3 samples (variation of 25.5±19.3%).

Conclusions The preliminary results demonstrated the feasibility of tracking cellular pharmacokinetics over time using high-quality dynamic data obtained from CIMR system, although tuning of the medium activity profile and further experimental validation are still on-going. $$graphic_C2450A5B-6F5F-4A57-A145-CCD0E211AD93$$

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tracking Cellular Pharmacokinetic Changes over Time based on Piecewise Modeling using a Continuously Infused Microfluidic Radioassay System
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Tracking Cellular Pharmacokinetic Changes over Time based on Piecewise Modeling using a Continuously Infused Microfluidic Radioassay System
Kuangyu Shi, Zhen Liu, Ziying Jian, Tao Cheng, Qian Wang, Benedikt Feuerecker, Markus Schwaiger, Sung-Cheng Huang, Sibylle Ziegler
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1062;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Tracking Cellular Pharmacokinetic Changes over Time based on Piecewise Modeling using a Continuously Infused Microfluidic Radioassay System
Kuangyu Shi, Zhen Liu, Ziying Jian, Tao Cheng, Qian Wang, Benedikt Feuerecker, Markus Schwaiger, Sung-Cheng Huang, Sibylle Ziegler
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1062;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

SPECIAL MTA: Novel Radiochemistry & Chelation Posters

  • Optimizing conditions to minimize antibody requirements for 89Zr radiolabeling
  • In vivo biodistribution of the nitric oxide donor, PRG150, using PET imaging in rats.
  • Dual Receptor-Targeting Tc-99m-Labeled RGD-Conjugated Alpha-MSH Hybrid Peptides for Human Melanoma Imaging
Show more SPECIAL MTA: Novel Radiochemistry & Chelation Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire